Trial Profile
Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus Research Project 2: T-cell and General Immune Responses to Influenza; Research Project 3: Single-cell Phospho-protein Signaling Analysis of the Response to Influenza Vaccination; Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 03 May 2017 Status changed from active, no longer recruiting to completed.
- 27 Nov 2013 New trial record